Heller Bridgette P 4

What Happened

• Bridgette P. Heller, a director of DexCom, Inc. (DXCM), received a grant of 5,575 restricted stock units (RSUs) on May 28, 2026. The award was granted at $0.00 per share (no cash paid at grant). Each RSU represents a contingent right to one share of DexCom common stock upon settlement.

Key Details

• Transaction date: 2026-05-28. Filing date (Accession): 2026-06-01 (filed timely under Form 4 rules).
• Transaction type: Award/Grant (code A). Shares/units granted: 5,575. Price: $0.00; total cash consideration at grant: $0.
• Vesting: 100% of the RSU award vests on the earlier of the one-year anniversary of the grant date or DexCom’s 2027 Annual Meeting of Stockholders (per footnote).
• Shares owned after transaction: Not reported in this Form 4 filing.
• No indication of a 10b5-1 plan, tax-withholding sale, or immediate sale of underlying shares in this filing.

Context

• This is a standard equity compensation grant for a director, giving a contingent right to receive shares upon vesting and settlement. Such grants are routine and are compensation, not a market purchase or sale — they do not by themselves signal buying/selling intent by the insider.